Bernardi, F.; D’Amico, F.; Bencardino, S.; Faggiani, I.; Fanizza, J.; Zilli, A.; Parigi, T.L.; Allocca, M.; Danese, S.; Furfaro, F.
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis. Pharmaceuticals 2024, 17, 347.
https://doi.org/10.3390/ph17030347
AMA Style
Bernardi F, D’Amico F, Bencardino S, Faggiani I, Fanizza J, Zilli A, Parigi TL, Allocca M, Danese S, Furfaro F.
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis. Pharmaceuticals. 2024; 17(3):347.
https://doi.org/10.3390/ph17030347
Chicago/Turabian Style
Bernardi, Francesca, Ferdinando D’Amico, Sarah Bencardino, Ilaria Faggiani, Jacopo Fanizza, Alessandra Zilli, Tommaso Lorenzo Parigi, Mariangela Allocca, Silvio Danese, and Federica Furfaro.
2024. "Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis" Pharmaceuticals 17, no. 3: 347.
https://doi.org/10.3390/ph17030347
APA Style
Bernardi, F., D’Amico, F., Bencardino, S., Faggiani, I., Fanizza, J., Zilli, A., Parigi, T. L., Allocca, M., Danese, S., & Furfaro, F.
(2024). Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis. Pharmaceuticals, 17(3), 347.
https://doi.org/10.3390/ph17030347
